Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLAL-PRED in Moderate to Severe Ulcerative Colitis
NCT00676832Phase 2Completed
- Sponsor
- Prometheus Laboratories
- Start
- May 2008
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisolone sodium metasulfobenzoate in ulcerative colitis (UC), sponsored by Prometheus Laboratories. Started May 2008; status: completed.
02
Drugs
prednisolone sodium metasulfobenzoate
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00676832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00676832.